The Japanese ENT device market was severely impacted by the COVID-19 pandemic in 2020, but it has since shown significant recovery and is anticipated to return to prepandemic trends in the coming…
The Japanese GI endoscopy device market was impacted negatively by the COVID-19 global pandemic, resulting in declines in procedure volumes, units sold, and overall market value in 2020. The market…
The global COVID-19 pandemic negatively impacted the Japanese heart valve device market to some extent. However, in the longer term, the market will be driven by positive results from THV device…
While the COVID-19 pandemic has significantly impacted the market in the short term, other factors, such as favorable demographics, will drive market growth once the impact of the pandemic has…
COVID-19 has negatively impacted the Japan transcatheter embolization and occlusion device market, but the impact of COVID-19 is limited and short term, the market will expand at a moderate rate…
The Japanese laparoscopic device market was negatively impacted by the COVID-19 pandemic. However, the overall market for laparoscopic devices will exhibit modest growth over the forecast period,…
The Japanese dialysis access treatment device market will be driven by significant rise in ESRD population and will grow modestly through 2031. New product launches such as DCB, DES, and…
Despite the negative impact of the COVID-19 pandemic in the short term, the Japanese IC device market will grow minimally through 2031, driven by aging population and expanding CAD patient pool,…
Given the urgent nature of the procedures, the Japanese trauma device market was impacted less severely by the COVID-19 pandemic. Going forward, favorable demographics and increasing presence of…
The global COVID-19 pandemic has had a relatively limited impact on the Japanese neurovascular device market in the short term, and the market will subsequently grow modestly through 2031, driven…
Growing adoption of premium-priced DES and DCBs will be fueled by the continued emergence of data supporting the safety of paclitaxel-coated devices, resulting in modest growth in the Japanese PV…
Despite the negative—albeit relatively limited—impact of the ongoing COVID-19 pandemic, the Japanese aortic repair device market will grow at a modest rate, which in turn is attributed to shift…
The Japanese interventional oncology device market saw a relatively limited impact of the COVID-19 pandemic, owing to the less elective nature of cancer procedures and progressively deteriorating…
Although the COVID-19 global pandemic has negatively impacted the Japanese EP mapping and ablation device market in the short term, the market has largely recovered and will resume moderate growth…
The COVID-19 pandemic has significantly impacted the Japanese large-joint reconstructive implant market, limiting hip and knee replacement procedures and unit sales. Following the impact of the…